For help on how to get the results you want, see our search tips.
1712 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Direct healthcare professional communication Remove Direct healthcare professional communication filter
Categories
Human Remove Human filter
-
List item
Human medicine European public assessment report (EPAR): Saxenda (updated)
liraglutide, Obesity; Overweight
Date of authorisation: 23/03/2015, Revision: 12, Authorised, Last updated: 29/06/2022 -
List item
Human medicine European public assessment report (EPAR): HBVaxPro (updated)
hepatitis B, recombinant surface antigen, Hepatitis B; Immunization
Date of authorisation: 27/04/2001, Revision: 30, Authorised, Last updated: 29/06/2022 -
List item
Human medicine European public assessment report (EPAR): Rotarix (updated)
human rotavirus, live attenuated, Immunization; Rotavirus Infections
Date of authorisation: 21/02/2006, Revision: 40, Authorised, Last updated: 29/06/2022 -
List item
Human medicine European public assessment report (EPAR): Luminity (updated)
perflutren, Echocardiography
Date of authorisation: 20/09/2006, Revision: 16, Authorised, Last updated: 29/06/2022 -
List item
Human medicine European public assessment report (EPAR): Keytruda (updated)
Pembrolizumab, Melanoma; Hodgkin Disease; Carcinoma, Renal Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Squamous Cell Carcinoma of Head and Neck; Urologic Neoplasms; Endometrial Neoplasms
Date of authorisation: 17/07/2015,
, Revision: 46, Authorised, Last updated: 29/06/2022
-
List item
Human medicine European public assessment report (EPAR): Olumiant (updated)
baricitinib, Arthritis, Rheumatoid
Date of authorisation: 13/02/2017, Revision: 10, Authorised, Last updated: 29/06/2022 -
List item
Human medicine European public assessment report (EPAR): Ambrisentan Mylan (updated)
ambrisentan, Hypertension, Pulmonary
Date of authorisation: 20/06/2019,
, Revision: 3, Authorised, Last updated: 29/06/2022
-
List item
Human medicine European public assessment report (EPAR): Spikevax (previously COVID-19 Vaccine Moderna) (updated)
CX-024414 (single-stranded, 5’-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2), COVID-19 virus infection
Date of authorisation: 06/01/2021,
, , 
, Revision: 24, Authorised, Last updated: 29/06/2022
-
List item
Human medicine European public assessment report (EPAR): Opsumit (updated)
Macitentan, Hypertension, Pulmonary
Date of authorisation: 20/12/2013,
, Revision: 20, Authorised, Last updated: 29/06/2022
-
List item
Human medicine European public assessment report (EPAR): Uptravi (updated)
Selexipag, Hypertension, Pulmonary
Date of authorisation: 12/05/2016, Revision: 13, Authorised, Last updated: 28/06/2022 -
List item
Human medicine European public assessment report (EPAR): Bemfola (updated)
follitropin alfa, Anovulation
Date of authorisation: 26/03/2014,
, Revision: 9, Authorised, Last updated: 28/06/2022
-
List item
Human medicine European public assessment report (EPAR): Prasugrel Mylan (updated)
prasugrel besilate, Myocardial Infarction; Acute Coronary Syndrome; Angina, Unstable
Date of authorisation: 15/05/2018,, Revision: 8, Authorised, Last updated: 28/06/2022
-
List item
Human medicine European public assessment report (EPAR): Starlix (updated)
nateglinide, Diabetes Mellitus, Type 2
Date of authorisation: 03/04/2001, Revision: 15, Withdrawn, Last updated: 28/06/2022 -
List item
Human medicine European public assessment report (EPAR): Sildenafil Actavis (updated)
sildenafil, Erectile Dysfunction
Date of authorisation: 10/12/2009,, Revision: 15, Authorised, Last updated: 28/06/2022
-
List item
Human medicine European public assessment report (EPAR): Bronchitol (updated)
mannitol, Cystic Fibrosis
Date of authorisation: 13/04/2012, Revision: 19, Authorised, Last updated: 27/06/2022 -
List item
Human medicine European public assessment report (EPAR): Optison (updated)
perflutren, Echocardiography
Date of authorisation: 17/05/1998, Revision: 19, Authorised, Last updated: 27/06/2022 -
List item
Human medicine European public assessment report (EPAR): Rozlytrek (updated)
Entrectinib, Cancer; Carcinoma, Non-Small-Cell Lung
Date of authorisation: 31/07/2020,, , Revision: 4, Authorised, Last updated: 27/06/2022
-
List item
Human medicine European public assessment report (EPAR): Forxiga (updated)
dapagliflozin propanediol monohydrate, Diabetes Mellitus, Type 2
Date of authorisation: 11/11/2012, Revision: 25, Authorised, Last updated: 27/06/2022 -
List item
Human medicine European public assessment report (EPAR): Edistride (updated)
dapagliflozin propanediol monohydrate, Diabetes Mellitus, Type 2; Diabetes Mellitus, Type 1
Date of authorisation: 09/11/2015, Revision: 20, Authorised, Last updated: 27/06/2022 -
List item
Human medicine European public assessment report (EPAR): Kiovig (updated)
human normal immunoglobulin (IVIg), Purpura, Thrombocytopenic, Idiopathic; Bone Marrow Transplantation; Immunologic Deficiency Syndromes; Guillain-Barre Syndrome; Mucocutaneous Lymph Node Syndrome
Date of authorisation: 18/01/2006, Revision: 26, Authorised, Last updated: 27/06/2022 -
List item
Human medicine European public assessment report (EPAR): Vocabria (updated)
Cabotegavir sodium, Cabotegravir, HIV Infections
Date of authorisation: 17/12/2020,, Revision: 5, Authorised, Last updated: 27/06/2022
-
List item
Human medicine European public assessment report (EPAR): Ozempic (updated)
semaglutide, Diabetes Mellitus
Date of authorisation: 08/02/2018,, Revision: 8, Authorised, Last updated: 27/06/2022
-
List item
Human medicine European public assessment report (EPAR): Votubia (updated)
everolimus, Tuberous Sclerosis
Date of authorisation: 02/09/2011,, Revision: 30, Authorised, Last updated: 27/06/2022
-
List item
Human medicine European public assessment report (EPAR): Afinitor (updated)
everolimus, Carcinoma, Renal Cell; Breast Neoplasms; Pancreatic Neoplasms
Date of authorisation: 02/08/2009, Revision: 30, Authorised, Last updated: 27/06/2022 -
List item
Human medicine European public assessment report (EPAR): Xalkori (updated)
crizotinib, Carcinoma, Non-Small-Cell Lung
Date of authorisation: 23/10/2012, Revision: 32, Authorised, Last updated: 27/06/2022